(R)-Isoxazolidin-4-ol hydrochloride

Catalog No.: 
ACUPJZ803
CAS No.: 
338464-48-5
Molecular Formula: 
C3H8ClNO2
Molecular Weight: 
125.56
(R)-Isoxazolidin-4-ol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$61.00In stockIn stock
250mg97%$91.00In stockIn stock
1g97%$223.00In stockInquiry
5g97%$692.00In stockInquiry
25g97%$3356.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-Isoxazolidin-4-ol hydrochloride
IUPAC Name(R)-isoxazolidin-4-ol hydrochloride
MDL No.MFCD20483792
Molecular FormulaC3H8ClNO2
Molecular Weight125.56
SMILESO[C@@H]1CNOC1.[H]Cl
InChI KeyLLCWGQYEQKYRDO-AENDTGMFSA-N
Synonym(R)-Isoxazolidin-4-ol hydrochloride | 338464-48-5 | (R)-Isoxazolidin-4-ol HCl | (4R)-1,2-Oxazolidin-4-ol;hydrochloride | 4-Isoxazolidinol, hydrochloride, (4R)- | MFCD20483792 | (R)-Isoxazolidin-4-olHydrochloride | SCHEMBL949828 | AKOS022186961 | (4R)-1,2-oxazolidin-4-ol hy
CAS No.338464-48-5
PubChem CID66853731

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACUPJZ803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUPJZ803 route product structure diagram
    ACUPJZ803338464-48-5In Stock
Inquiry

2. ACUPJZ803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUPJZ803 route product structure diagram
    ACUPJZ803338464-48-5In Stock
Inquiry

3. ACUPJZ803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUPJZ803 route product structure diagram
    ACUPJZ803338464-48-5In Stock
Inquiry

Comments (0)